Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna. . That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
As the Covid-19 crisis intensifies in the United States, the fight for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek authorization from the Food and Drug Administration for its Covid-19 vaccine starting in October. Meanwhile, the federal government’s Covid-19 vaccine …
Read More »
Text size Mladen Antonov / AFP / Getty Images As the new coronavirus pandemic continues in the U.S., people yearn for a victory after Washington’s spectacular failures to secure adequate supplies of test kits and personal protective equipment. Success depends on whether any of the candidates for the fast-track Covid-19 …
Read More »
Text size The Tesla showroom and service center in Amsterdam. (Photo by JOHN THYS / AFP via Getty Images) AFP via Getty Images This conversation with Baillie Gifford’s partner and global equity chief James Anderson about Tesla’s shares is excerpted from Barron’s recent mid-year Roundtable, released on July 10. To …
Read More »